Sangamo Therapeutics Inc
General ticker "SGMO" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $452.1M
Sangamo Therapeutics Inc follows the US Stock Market performance with the rate: 46.9%.
Estimated limits based on current volatility of 8.8%: low 2.33$, high 2.78$
Factors to consider:
- Current price 70.9% above estimated high
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.40$, 1.40$]
- 2024-12-30 to 2025-12-30 estimated range: [0.80$, 2.32$]
Financial Metrics affecting the SGMO estimates:
- Negative: Non-GAAP EPS, $ of -0.93 <= 0.10
- Negative: Operating profit margin, % of -60.86 <= 1.03
- Negative: Operating cash flow per share per price, % of -75.09 <= 2.35
- Negative: negative Net income
- Negative: Industry operating profit margin (median), % of -98.30 <= 2.14
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
Short-term SGMO quotes
Long-term SGMO plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $110.70MM | $111.30MM | $176.23MM |
| Operating Expenses | $294.04MM | $312.58MM | $450.24MM |
| Operating Income | $-183.34MM | $-201.28MM | $-274.00MM |
| Non-Operating Income | $5.35MM | $9.43MM | $11.10MM |
| R&D Expense | $230.82MM | $249.90MM | $234.06MM |
| Income(Loss) | $-177.99MM | $-191.85MM | $-262.90MM |
| Taxes | $0.31MM | $0.43MM | $-5.07MM |
| Profit(Loss) | $-178.30MM | $-192.28MM | $-257.83MM |
| Stockholders Equity | $375.34MM | $294.96MM | $82.89MM |
| Inventory | $88.17MM | $0.00MM | $0.00MM |
| Assets | $721.92MM | $562.51MM | $165.32MM |
| Operating Cash Flow | $-233.25MM | $-223.63MM | $-224.84MM |
| Capital expenditure | $23.28MM | $20.17MM | $21.16MM |
| Investing Cash Flow | $248.20MM | $59.28MM | $153.53MM |
| Financing Cash Flow | $32.86MM | $84.66MM | $14.59MM |
| Earnings Per Share* | $-1.23 | $-1.25 | $-1.48 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.